Jeffrey White, MD, Oncology, Lansdowne, VA, Inova Loudoun Hospital


Oncology Lansdowne, VA

Hematologic Oncology

Associate Director, Office of Cancer Complementary and Alternative Medicine, National Cancer Institute, NIH

Dr. White is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. White's full profile

Already have an account?

Education & Training

  • Georgetown University Hospital - Washington Hospital Center
    Georgetown University Hospital - Washington Hospital CenterFELLOWSHIP
  • Georgetown University Hospital - Washington Hospital Center
    Georgetown University Hospital - Washington Hospital CenterRESIDENCY
  • Howard University College of Medicine
    Howard University College of MedicineMEDICAL_SCHOOL
  • Cornell UniversityOTHER_TRAINING

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1989 - 2022
  • DC State Medical License
    DC State Medical License 1987 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
  • Leading Diversity Award National Cancer Institute, 2011
  • Merit Award National Institutes of Health, 2010
  • Join now to see all

Publications & Presentations


Journal Articles

  • The National Cancer Institute Best Case Series Program: A Summary of Cases of Cancer Patients Treated With Unconventional Therapies in India  
    Olaku O, Zia F, Santana JM, and White JD, Integr Cancer Ther, 1/1/2013
  • Proceedings of the Indo-US bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment and survival  
    Kumar NB, Dhurandhar M, Aggarwal B, Anant S, Kenyon D, Deng G, Djeu J, Dou, J, Hawk E, Jayaram B, Jia L, Joshi R, Karkarala M, Karunagaran D, Kucuk O, Kumar L, Malafa ..., Cancer Medicine, 1/1/2013
  • Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment  
    Wang E, Bussom S, Chen J, Quinn C, Bedognetti D, Lam W, Guan F, Jiang Z, Mark Y, Zhao Y, Stroncek DF, White J, Marincola FM and Cheng YC, BMC Medical Genomics, 1/1/2011
  • Join now to see all

Books/Book Chapters


  • Complementary and alternative medicine use by Hispanic cancer patients and the impact of acculturation: National Health Interview Survey 2007.
    Santana J, Olaku O, White J, Zia F, 139th APHA Annual Meeting (Alternative and Complementary Health Practices), 1/29/2011
  • Yttrium-90 Radiolabeled Daclizumab, an Anti-CD25 Monoclonal Antibody, Provides Effective Therapy for Refractory and Relapsed Hodgkin's Lymphoma.
    Janik JE, Morris JC, Conlon KC, O'Mahony D, Pittaluga S, Jaffe ES, Brechbiel MW, Paik CH, Whatley M, Fleisher TA, White JD, Steward DM, Fioravanti S, Lee CC, Goldman C..., American Society of Hematology Annual Meeting, 1/1/2011
  • Effects of stress on cancer treatment effectiveness: a literature review of animal models.
    Kawa S and White JD, American Psychosomatic Society 68th Annual Scientific Meeting, Portland, OR, 1/10/2010
  • Join now to see all


  • Prevention and Treatment on Cancer in Integrative Medicine. 
    Tokyo, Japan - 1/17/2012
  • Nutraceuticals, Herbs, and Society. 
    Georgetown University Medical Center - 1/12/2012
  • President's Cancer Panel: America's Demographic and Cultural Transformation Implications for the Cancer Enterprise. 
    Miami, FL - 1/2/2010
  • Join now to see all


  • National Cancer Institute's Support of Research to Further Integrative Oncology Practice. 
    White JD, JNCI Monographs
  • New Trend in Cancer Therapy 
    White JD, Hodo Tokushu (News Special), TBS News
    Tokyo, Japan - 1/16/2004

Hospital Affiliations